Table 1.
Baseline Characteristics Between Two Groups Based on the Use of Sodium Thiosulfate
| Parameters (Unit, N) | All Cases | STS Group (N = 20) | No STS (N=10) |
|---|---|---|---|
| Demographics | |||
| Age (years, N=30) | 65.6 ± 12.79 | 63.5 ± 13.25 | 69.3 ± 11.54 |
| Sex (male: female, N=30) | 8: 22 | 2: 8 | 6: 14 |
| BMI (kg/m2, N = 29) | 33.52 ± 9.54 | 32.85 ± 9.85 | 35 ± 9.17 |
| Current or past smokers | 14 | 9 | 5 |
| HD (N =15), months* | 22.5, 0.2 – 216 | 20, 0.2–96 (11) | 60, 3–216 (3) |
| PD (N=8), months | 29 ± 10 | 33.67 ± 10.60 (3) | 24.33 ± 9.87 (3) |
| No dialysis | 7 | 4 | 3 |
| Chronic Co-Morbidities | |||
| Cirrhosis | 1 | 1 | |
| DM | 20 | 13 | 7 |
| CAD and/or PAD | 17 | 10 | 7 |
| Chronic Steroid Use | 1 | 1 | |
| Laboratory Parameters | |||
| Albumin (g/dl, N=27) | 4.1 ± 3.06 | 3.0 ± 0.58 (19) | 3.2 ± 0.66 (8) |
| Calcium (mg/dl, N = 28) | 9.26 ± 0.86 | 9.25 ± 0.96 (20) | 9.3 ± 0.57 (8) |
| Phosphorous (mg/dl, N = 27) | 5.57 ± 2.78 | 5.09 ± 2.29 (19) | 6.73 ± 3.63 (8) |
| Parathyroid hormone (pg/mL, N=23)* | 239.8, 4.7 – 2922 | 216, 4.7–2922 (18) | 246.3, 204.9–764.7 (5) |
| INR (N=25) | 1.39 ± 0.82 | 1.5 ± 0.93 (18) | 1.1 ± 0.26 (7) |
| ESR (mm/hr, N=11) | 90.1 ± 31.79 | 95.7 ± 27.18 (10) | 34 (1) |
| CRP (mg/dl, N=12)* | 2.53, 0.4–36.6 | 6.05, 0.4–36.6 (9) | 2.53, 2–2.53 (3) |
| Ferritin (mg/dl, N=11) | 788.32 ± 404.03 | 824.42 ± 406.76 (10) | 427.3 (1) |
Notes: All data are expressed as numbers, mean ± standard deviation or median and range (*) as appropriate. Missing data were excluded from calculations.
Abbreviations: BMI, body mass index; CAD, coronary artery disease; DM, diabetes mellitus; HD, hemodialysis; INR, international normalized ratio; PAD, peripheral arterial disease; PD, peritoneal dialysis; STS, sodium thiosulfate.